CD274 and neoplasm: Through the analysis of tumor‐infiltrating T cells at remote tumor sites (Figure 8K), they found that the number of T cells increased during the treatment with WO2.9‐WSe2, and the strongest immune response was triggered after treatment with WO2.9‐WSe2 and anti‐PD–L1 antibody under NIR and X‐ray irradiation.